Arizona Bioscience News: NAU’s $21M grant; C-Path names CEO; Liver disease in Latino youth

September 30, 2022

By Jessica Vaile

NAU earns $21M grant to continue work into health equity in the Southwest / AZ Big Media

The Center for Health Equity Research at Northern Arizona University received another $21 million grant to continue its work to promote health equity and study health disparities among diverse populations of the American Southwest, five years after it was initially funded with a grant of the same size.

C-Path names Daniel Jorgensen CEO / Contract Pharma

Dr. Daniel M. Jorgensen, an experienced leader in drug development, health care and business, has been named CEO of the Tucson-based Critical Path Institute, effective Oct. 1.

TGen researching liver disease in Latino youth / Arizona’s Family

Translational Genomics Research Institute, Arizona State University and Phoenix Children’s Hospital are working together to help research nonalcoholic fatty liver disease, or NAFLD, that’s rising among children, especially Latino youth.

UArizona plays a massive role in aging research / KVOA

September is Healthy Aging Month, and scientists at the University of Arizona are playing a major role in explaining how we understand the aging brain as part of a $60 million study.

Learn about health innovation during Arizona Bioscience Week / ABC 15

Joan Koerber-Walker, president and CEO of Arizona Bioindustry Association, talks about Arizona Bioscience Week events and the state’s bioscience ecosystem in this sit-down interview.

Abrazo says Buckeye medical campus construction to begin in coming months / Phoenix Business Journal

Abrazo Health, which at the beginning of the year announced plans to build a new medical campus on a 27-acre parcel in Buckeye, said construction is expected to begin in the coming months. Meanwhile, Banner Health has also announced its plans to build a hospital in Buckeye, which will be across the street from the Abrazo campus.

Banner Health announces new blood test that can detect premature birth / Arizona’s Family

Banner Health is offering a new test—the PreTRM®— for expecting mothers that can detect if a child will be born early.

Upcoming Events / 

October 5: Flinn Foundation Bioscience Entrepreneurship Program info session

Sign up to receive Arizona Bioscience News weekly

Search the Arizona BioMap